Insights From Our Labs to Yours
Covance Blog
“You say tomato, I say tomato,” were lyrics in a popular 1930s Gershwin song highlighting variations in dialects (to-may-to vs. to-mah-to). Nearly a century later, regional differences exist across dialects – and even within the terminology used by global companies. Even ours. With several early development laboratories across Covance, LabCorp’s …
To deliver on the mission of improving health and improving lives, patients need access to safe and effective treatments. As part of safety testing, abnormal toxicity tests, also known as general safety tests, are often performed when a drug manufacturer creates a batch of its licensed pharmaceutical or biotechnology-derived product.
With over half a billion people worldwide suffering from a chronic respiratory condition and cases of COVID-19 climbing above 25 million globally, pulmonary drug delivery via specialist inhalation devices is more relevant than ever. Pulmonary drugs offer the best potential for optimal delivery to the lungs while minimizing systemic side …
Covance helped to launch a COVID-19 study in a record-breaking 14 business days, as discussed in an earlier article – but what happened next? We followed up with some of the Covance employees who are helping to advance a small U.S. biotech’s clinical trial to its next phases and study …
Matt Renninger, site head for our early development (ED) business in China and global head of pathology and statistics for ED, recently shared his journey of moving from Indiana to Shanghai and the experience of becoming integrated with a new culture and team.
Potency evaluation, achieved through potency assays, is essential to transition an advanced therapy medicinal product or ATMP (also known as cell and gene therapy) through pivotal clinical stages to final market authorization. However, potency is a difficult parameter to assess for ATMPs, so it is important to start developing these …
Our “Meet Me in 5” series covers 5 people, topics or questions to illustrate how our business nurtures exceptional people, provides an energizing purpose and enables extraordinary potential in its employees’ careers. Every day counts in the fight against the COVID-19 pandemic. That’s why Covance, LabCorp’s drug development business, was …
In vivo respiratory disease models are valuable in the identification of potential medications targeted at treating human respiratory diseases. Common respiratory diseases include lung fibrosis or the emerging COVID-19, where highly efficacious treatments are limited and where in vivo disease models can help to screen for potential new treatments. In …
One hundred years ago, as women gained the right to vote in the United States, building on the progress of women’s movements around the world, women’s rights leader Alice Paul said: “I always feel the movement is a sort of mosaic. Each of us puts in one little stone, and …
Assessing in vitro steroidogenesis endpoints is an important early step in establishing the endocrine disruptor (ED) potential of your crop protection product. Many regulators worldwide now require this information as part of the registration and approval process; for example, in the E.U., the updated pesticide and biocide directives now requests …